Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Disease and TLL1[original query] |
|---|
| Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial. Circulation 2011 Sep 124 (13): 1426-34. Cresci Sharon, Wu Jun, Province Michael A, Spertus John A, Steffes Michael, McGill Janet B, Alderman Edwin L, Brooks Maria Mori, Kelsey Sheryl F, Frye Robert L, Bach Richard G, |
| Association of TLL1 gene polymorphism (rs1503298, T > C) with coronary heart disease in PREDICT, UDACS and ED cohorts. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2014 Sep 24 (9): 615-9. Zain Maryam, Awan Fazli Rabbi, Cooper Jackie A, Li Ka Wah, Palmen Jutta, Acharya Jay, Howard Philip, Baig Shahid M, Elkeles Robert S, Stephens Jeffrey W, Ireland Helen, Humphries Steve |
| Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. Journal of gastroenterology 2017 Jul . Seko Yuya, Yamaguchi Kanji, Mizuno Naoki, Okuda Keiichiro, Takemura Masashi, Taketani Hiroyoshi, Hara Tasuku, Umemura Atsushi, Nishikawa Taichiro, Moriguchi Michihisa, Yasui Kohichiroh, Kamaguchi Mai, Nishioji Kenichi, Mochizuki Naomi, Kobayashi Masao, Mori Kojiroh, Tanaka Saiyu, Matsuura Kentaro, Tanaka Yasuhito, Itoh Yoshi |
| Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis. Seminars in liver disease 2019 Mar . Fujiwara Naoto, Hoshida Yuj |
| Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. International journal of molecular sciences 2020 Apr 21 (9): . Enomoto Hirayuki, Aizawa Nobuhiro, Hasegawa Kunihiro, Ikeda Naoto, Sakai Yoshiyuki, Yoh Kazunori, Takata Ryo, Yuri Yukihisa, Kishino Kyohei, Shimono Yoshihiro, Ishii Noriko, Takashima Tomoyuki, Nishimura Takashi, Nishikawa Hiroki, Iwata Yoshinori, Iijima Hiroko, Nishiguchi Shuh |
| Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling. Hepatology communications 2020 Feb 4 (2): 255-267. Kiso Ayumi, Toba Yukiko, Tsutsumi Susumu, Deguchi Sayaka, Igai Keisuke, Koshino Saki, Tanaka Yasuhito, Takayama Kazuo, Mizuguchi Hiroyu |
| Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease. PloS one 2020 15 (12): e0243590. Bayoumi Ali, Jalil Ismail, Metwally Mayada, Adams Leon A, Aller Rocio, García-Monzón Carmelo, Arias-Loste María Teresa, Miele Luca, Petta Salvatore, Craxì Antonio, Gallego-Durán Rocio, Fischer Janett, Berg Thomas, Qiao Liang, Liddle Christopher, Bugianesi Elisabetta, Romero-Gomez Manuel, George Jacob, Eslam Mohamm |
| Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients. Genes 2021 05 12 (6): . Agwa Sara H A, Kamel Marwa Mostafa, Elghazaly Hesham, Abd Elsamee Aya M, Hafez Hala, Girgis Samia Abdo, Ezz Elarab Hoda, Ebeid Fatma S E, Sayed Safa Matbouly, Sherif Lina, Matboli Mar |
| Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans. Annals of hepatology 2023 11 101181. Siyu Fu, Dhamina Karim, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z Mattos, Marco Arrese, Enrique Carrera, Jeffrey Oliveira, Jose D Debes, Andre Boonst |
- Page last reviewed:Feb 1, 2024
- Content source: